IntrinsicIntrinsic
← Scroll for more →

Financial Statements — IREN

Balance Sheet

(in billions USD)
MetricQ3 2026Q2 2026Q1 2026Q1 2025Q3 2024Q1 2024Q3 2023Q1 2023
Cash & Equivalents2.213.261.030.180.100.260.060.03
Total Current Assets2.423.381.120.260.160.31----
Total Assets7.267.034.27----------
Total Current Liabilities0.650.680.200.550.150.04----
Total Liabilities4.604.521.39----------
Retained Earnings(0.61)(0.37)(0.21)(0.69)(0.73)(0.66)----
Total Stockholder Equity2.662.512.881.431.130.680.310.27
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q1 2025Q4 2024Q3 2024Q1 2024Q4 2023Q3 2023Q1 2023Q4 2022Q4 2021
Interest Expense----------------------9.870.80
Pretax Income(691.97)(254.09)(337.93)575.3029.2721.87(50.42)12.11(6.29)(4.48)(2.73)(144.36)73.47
Tax Provision(7.97)(6.26)(182.52)190.695.043.001.283.47(1.06)0.820.32(0.41)3.15
Net Income(684.00)(247.83)(155.41)384.6124.2318.88(51.71)8.64(5.23)(5.30)(3.05)(143.95)70.32
Basic EPS--(0.74)(0.52)1.420.000.00-0.000.08-0.00-0.00(0.06)(2.71)1.90
Diluted EPS--(0.74)(0.52)1.080.000.00-0.000.08-0.00-0.00(0.06)(2.71)(0.68)
← Scroll for more columns →

Cash Flow Statement

(in billions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q3 2024Q3 2023
Operating Cash Flow1.810.080.070.14(0.05)(0.03)
Capital Expenditures1.330.950.540.18----
Free Cash Flow*0.48(0.87)(0.47)(0.04)----
Investing Cash Flow(2.11)(1.48)(0.85)(0.28)(0.34)0.02
Financing Cash Flow5.710.363.010.610.080.01
← Scroll for more columns →

* Derived from reported values

Dividends Per Share

(USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026
Dividends Per Share0.000.000.000.00
← Scroll for more columns →